The Medical Research Council Clinical Trials Unit (MRC CTU) at UCL is
at the forefront of resolving internationally important questions in infectious
diseases and cancer, and delivering swifter and more effective translation of
scientific research into patient benefits. It does this by carrying out
challenging and innovative studies, and developing and implementing
methodological advances in study design, conduct and analysis.
- Focus on internationally
important questions, through challenging and innovative studies,
concentrating on infectious diseases and cancer
- Put methodology firmly at the
heart of our work to drive innovation in study design, conduct and
analysis so that scientific progress is translated into clinical benefit
more rapidly and effectively
- Further develop our external
links, including our mentoring role.